0000950170-23-067875.txt : 20231204
0000950170-23-067875.hdr.sgml : 20231204
20231204190626
ACCESSION NUMBER: 0000950170-23-067875
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231130
FILED AS OF DATE: 20231204
DATE AS OF CHANGE: 20231204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Toole David D
CENTRAL INDEX KEY: 0001491140
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39059
FILM NUMBER: 231464765
MAIL ADDRESS:
STREET 1: 1640 MARENGO STREET
CITY: LOS ANGELES
STATE: CA
ZIP: 90033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVITA Medical, Inc.
CENTRAL INDEX KEY: 0001762303
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 202578762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 28159 AVENUE STANFORD
STREET 2: SUITE 220
CITY: VALENCIA
STATE: CA
ZIP: 91355
BUSINESS PHONE: 661-568-1317
MAIL ADDRESS:
STREET 1: 28159 AVENUE STANFORD
STREET 2: SUITE 220
CITY: VALENCIA
STATE: CA
ZIP: 91355
FORMER COMPANY:
FORMER CONFORMED NAME: Avita Therapeutics, Inc.
DATE OF NAME CHANGE: 20200630
FORMER COMPANY:
FORMER CONFORMED NAME: Avita Medical, Ltd.
DATE OF NAME CHANGE: 20181218
4
1
ownership.xml
4
X0508
4
2023-11-30
0001762303
AVITA Medical, Inc.
RCEL
0001491140
O'Toole David D
28159 AVENUE STANFORD
SUITE 220 - AVITA MEDICAL
VALENCIA
CA
91355
false
true
false
false
CFO
false
Common Stock
2023-11-30
4
A
false
1034
9.061
A
16034
D
Common Stock
2023-12-01
4
P
false
500
10.68
A
16534
D
These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on July 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period).
/s/ Donna Shiroma
2023-12-04